http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011229491-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90f4ee566d9768b969cde8b1de75ad0d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-535 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-535 |
| filingDate | 2011-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_465d7e2ec33af7647397f526b109ce20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_383c1822ae1363c5f383bdabb089f71c |
| publicationDate | 2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2011229491-B2 |
| titleOfInvention | Method for obtaining biologically active recombinant human G-CSF |
| abstract | Provided is a method of obtaining biologically active recombinant human G-CSF from inclusion bodies, wherein the solubilization and refolding process can be performed at ambient temperature and the purification step comprises reversed phase chromatography (RP), in particular RP-HPLC. The G-CSF preparation so obtained is characterized by high purity and homogeneity. |
| priorityDate | 2010-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.